Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.9321112319403448 | N/A |
Market Cap | $552.81M | N/A |
Shares Outstanding | 593.07M | N/A |
Employees | 1.13K | N/A |